Summary
- Current Price
- As of today, RGEN price is $143.60, up +1.68% on
- Current Price All-Time High
- RGEN price is currently -56.13% below its historical high of $327.32 set on
- Market Cap
- RGEN current market cap is $8B, up +23.06% over the past 365 days
- PE Ratio
- RGEN current PE ratio is 195.72
- Revenue
- RGEN current annual revenue is $738.26M, up +16.36% year-over-year
- Next Earnings
- The next earnings release for RGEN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Repligen Corporation |
| Ticker | NASDAQ: RGEN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | repligen.com |
| Employees | 1,778 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $143.60 | |
| Price, 1D Change | +1.68% | |
| $8B | ||
| - | ||
| 195.72 | ||
| 1.21 | ||
| $738M | ||
| Revenue, 1Y Change | +16.36% | |
| $0.86 | ||
| EPS, 1Y Change | +289.52% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.86 | ||
| EPS Estimate | N/A | $2.00 |
| EPS Est. Change | N/A | +131.59% |
| $738.26M | ||
| Revenue Estimate | N/A | $821.04M |
| Revenue Est. Change | N/A | +11.21% |
| Current Price | $143.60 | |
| Price Target | - | $180.00 |
| Price Tgt. Change | - | +25.35% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.53 | -$0.46 | -129.72% | |
| $1.67 | $0.86 | -48.18% | |
| $2.00 | N/A | +131.59% | |
| $2.55 | N/A | +195.07% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $634.06M | $634.44M | +0.06% | |
| $732.50M | $738.26M | +0.79% | |
| $821.04M | N/A | +11.21% | |
| $944.20M | N/A | +27.90% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $143.60 | |
| $139.80 | ||
| $133.03 | ||
| $134.36 | ||
| $135.21 | ||
| $1.57 | ||
| 1.21 | ||
| $7.96 | ||
| 54.94 | ||
| 73.11% | ||
| 46.58% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $738.26M | ||
| $0.86 | ||
| $347.62M | ||
| 47.50% | ||
| $59.58M | ||
| 8.07% | ||
| $48.89M | ||
| 6.62% | ||
| $138.32M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.33 | ||
| 8.37 | ||
| 7.12 | ||
| - | ||
| 7 | ||
| 6.71 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 195.72 | ||
| 10.32 | ||
| 3.84 | ||
| 46.20 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $2.11B | ||
| $767.63M | ||
| $2.95B | ||
| $1.14B | ||
| $843.57M | ||
| $135.83M | ||
| $689.95M | ||
| $21.56M | ||
| $30.01M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $689.36M | ||
| $288.05M | ||
| $390.63M | ||
| $0.00 | ||
| $96.96M | ||
| $0.00 | ||
| $13.49M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $117.42M | ||
| -$298.47M | ||
| -$15.21M | ||
| $25.73M | ||
| $91.69M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Benchmark | → | |
| Evercore ISI Group | → | |
| HSBC | → | |
| JP Morgan | → | |
| Barclays | → | |
| Canaccord Genuity | → | |
| Roth Capital | ||
| Barclays | → | |
| Evercore ISI Group | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with RGEN
FAQ
What is the ticker symbol for Repligen Corporation?
The ticker symbol for Repligen Corporation is NASDAQ:RGEN
Does Repligen Corporation pay dividends?
No, Repligen Corporation does not pay dividends
What sector is Repligen Corporation in?
Repligen Corporation is in the Healthcare sector
What industry is Repligen Corporation in?
Repligen Corporation is in the Medical Instruments & Supplies industry
What country is Repligen Corporation based in?
Repligen Corporation is headquartered in United States
When did Repligen Corporation go public?
Repligen Corporation initial public offering (IPO) was on April 29, 1986
Is Repligen Corporation in the S&P 500?
No, Repligen Corporation is not included in the S&P 500 index
Is Repligen Corporation in the NASDAQ 100?
No, Repligen Corporation is not included in the NASDAQ 100 index
Is Repligen Corporation in the Dow Jones?
No, Repligen Corporation is not included in the Dow Jones index
When was Repligen Corporation last earnings report?
Repligen Corporation's most recent earnings report was on July 28, 2026
When does Repligen Corporation report earnings?
The next expected earnings date for Repligen Corporation is November 3, 2026
Data Sources & References
- RGEN Official Website www.repligen.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/730272/000119312526076528/0001193125-26-076528-index.htm
- RGEN Profile on Yahoo Finance finance.yahoo.com/quote/RGEN
- RGEN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rgen